Clinical Trials

120 enrolled

Prostatic Neoplasms

NCT06401980 2026-03-30

Darolutamide in Metastatic Castration-Resistant Prostate Cancer (mCRPC)

162 enrolled

Metastatic Castration-resistant Prostate Cancer

NCT06391099 2026-03-19

Ketogenic Dietary Intervention to Improve Response to Immunotherapy in Patients With Metastatic Melanoma and Metastatic Kidney Cancer

DermatologicGenitourinary

60 enrolled

Carcinoma, Renal Cell, Melanoma

NCT06422455 2026-03-18

Access to Genetic Testing in Underserved Patients With Cancer

BreastGenitourinaryGynecologic

800 enrolled

Breast Neoplasms, Ovarian Neoplasms, Prostatic Neoplasms, Breast Neoplasms, Male, Triple Negative Breast Neoplasms

NCT07302230 2026-03-13

EMPOWER

100 enrolled

Urinary Bladder Neoplasms

NCT06528990 2026-03-05

Telehealth Intervention for Ostomy Self-Management

GastrointestinalGenitourinary

150 enrolled

Urinary Bladder Neoplasms, Colorectal Neoplasms

NCT06040762 2026-03-02

A Home-Based Prehabilitation Exercise Intervention for Improving Physical Function in Patients With Bladder Cancer and Upper Tract Urothelial Cancer, Get Moving Trial

128 enrolled

Urinary Bladder Neoplasms, Carcinoma, Transitional Cell

NCT06855277 2026-02-24

AcTFirst

940 enrolled

Prostatic Neoplasms

NCT06563388 2026-02-04

ID-COMET

GastrointestinalGenitourinaryThoracic

800 enrolled

Colonic Neoplasms, Lung Neoplasms, Prostatic Neoplasms

NCT07218718 2026-01-28

Oral Cryotherapy to Decrease Taste Changes in Prostate Cancer Patients Receiving Taxane Chemotherapy

60 enrolled

Prostatic Neoplasms

NCT06296147 2026-01-16

Virtual Reality Headset and/or Aromatherapy for Patients Undergoing a Transperineal Prostate Biopsy

208 enrolled

Prostatic Neoplasms

NCT03151629 2026-01-06

IRONMAN

Recruiting

5,000 enrolled

Prostatic Neoplasms

NCT05519878 2025-12-24

Light Therapy and Occupational Therapy Fatigue Management-Based Intervention for Patients With Genitourinary Cancers

224 enrolled

Urinary Bladder Neoplasms, Carcinoma, Renal Cell, Prostatic Neoplasms

NCT07087860 2025-12-09

RECIPE-B1

70 enrolled

Urinary Bladder Neoplasms, Ureteral Neoplasms

NCT06046131 2025-11-17

KP-CARAIBES

3,000 enrolled

Adenocarcinoma, Neoplasm Metastasis, Prostatic Neoplasms, Recurrence

NCT05454488 2025-11-14

An Evidence-Based Focal Cryotherapy Protocol for Focal Ablation of Intermediate Risk Prostate Cancer

30 enrolled

Prostatic Neoplasms

NCT06014255 2025-10-29

HEAT

219 enrolled

Prostatic Neoplasms

NCT04751435 2025-10-21

IMAGINE

BreastGastrointestinalGenitourinaryGynecologic

445 enrolled

Breast Neoplasms, Ovarian Neoplasms, Pancreatic Neoplasms, Prostatic Neoplasms, Colorectal Neoplasms

NCT05754658 2025-10-06

African Cancer Genome: GMD

Recruiting

1,500 enrolled

BreastGenitourinary

Breast Neoplasms, Prostatic Neoplasms

NCT07126860 2025-08-17

ZMoveMent-1

150 enrolled

Psychological Well-Being, Motor Activity, Prostatic Neoplasms

NCT07053462 2025-07-08

CRISPR-Edited HLA Donor Kidney Transplant to Reduce Rejection Risk

Phase 1/2 Recruiting

90 enrolled

Carcinoma, Renal Cell, Kidney Failure, Chronic, Renal Insufficiency

NCT06903312 2025-07-03

ITALIC-RCC

Phase 4 Recruiting

409 enrolled

Carcinoma, Renal Cell, Kidney Neoplasms

NCT06625970 2025-06-26

PEACE 7

700 enrolled

Prostatic Neoplasms

NCT06496581 2024-12-20

Standard of Care +/- 177Lu-PSMA-617 In de Novo mHSPC Patients With Poor PSA Response (PEACE6-Poor Responders)

500 enrolled

Genital Diseases, Male, Prostatic Diseases

NCT06636682 2024-10-21

FK-PC101 as Adjuvant Therapy for Men With High-Risk Prostate Cancer

100 enrolled

Adenocarcinoma, Prostatic Neoplasms

NCT04694924 2024-05-22

Prosquare

Recruiting

5,000 enrolled

Prostatic Neoplasms

NCT05209243 2023-05-19

START-MET

266 enrolled